Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-19956954694299.8120.20.10.10.00.099.83.0
Gambia1993-199712312198.421.61.60.00.00.098.41.0
India - Barshi1993-20004747100.000.00.00.00.00.0100.01.6
India - Karunagappally1991-1997545398.111.91.90.00.00.098.13.5
Thailand - Chiang Mai1993-199770563890.5679.57.11.10.40.991.42.1
Thailand - Lampang1990-20001455145299.830.20.00.00.20.099.82.2
Thailand - Songkhla1990-199927121679.75520.316.62.60.40.780.43.0
Uganda - Kampala1993-199711610187.11512.912.10.00.90.087.15.9
Zimbabwe - Harare1993-199713213199.210.80.80.00.00.099.21.0



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period